On Monday, shares of Intellia Therapeutics Inc (NTLA) surged over 10.3%, closing at $11.45, surpassing their 200-day moving average of $11.35. This significant movement follows a year-long trading range for NTLA, with a low of $5.90 and a high of $28.25.
The stock’s performance highlights a notable recovery and investor confidence, as NTLA continues to trend positively in the market.
